These results suggest that through alleviating ferroptosis inhibition and gemcitabine resistance induced by METTL3 overexpression, HMGB1 contributes to cellular responses in pancreatic cancer cells. This evidence concerns the gene HMGB1 and pancreatic neoplasm.